JPS6124597A - 抗糖尿病剤 - Google Patents
抗糖尿病剤Info
- Publication number
- JPS6124597A JPS6124597A JP59145189A JP14518984A JPS6124597A JP S6124597 A JPS6124597 A JP S6124597A JP 59145189 A JP59145189 A JP 59145189A JP 14518984 A JP14518984 A JP 14518984A JP S6124597 A JPS6124597 A JP S6124597A
- Authority
- JP
- Japan
- Prior art keywords
- ginseng
- ginsenoside
- beta
- antidiabetic agent
- glucopyranoside
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003472 antidiabetic agent Substances 0.000 title claims abstract description 6
- 229940125708 antidiabetic agent Drugs 0.000 title claims abstract description 6
- 239000004480 active ingredient Substances 0.000 claims description 2
- 235000008434 ginseng Nutrition 0.000 abstract description 9
- 241000208340 Araliaceae Species 0.000 abstract description 7
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 abstract description 7
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract description 7
- 229930182490 saponin Natural products 0.000 abstract description 7
- 150000007949 saponins Chemical class 0.000 abstract description 7
- 235000017709 saponins Nutrition 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 6
- 229930182494 ginsenoside Natural products 0.000 abstract description 6
- 229940089161 ginsenoside Drugs 0.000 abstract description 6
- NODILNFGTFIURN-GZPRDHCNSA-N ginsenoside Rb2 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O NODILNFGTFIURN-GZPRDHCNSA-N 0.000 abstract description 5
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 abstract description 5
- PFSIGTQOILYIIU-UHFFFAOYSA-N ginsenoside Rb3 Natural products CC(=CCCC(C)(O)C1CCC2(C)C3CCC4C(C)(C)C(CCC4(C)C3CC(OC5OC(COC6OCC(O)C(O)C6O)C(O)C(O)C5O)C12C)OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C PFSIGTQOILYIIU-UHFFFAOYSA-N 0.000 abstract description 5
- ZTQSADJAYQOCDD-UHFFFAOYSA-N ginsenoside-Rd2 Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OCC(O)C(O)C1O ZTQSADJAYQOCDD-UHFFFAOYSA-N 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 5
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 abstract description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract description 3
- 229920002261 Corn starch Polymers 0.000 abstract description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 abstract description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract description 2
- 240000004371 Panax ginseng Species 0.000 abstract description 2
- 235000002789 Panax ginseng Nutrition 0.000 abstract description 2
- 239000008120 corn starch Substances 0.000 abstract description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 abstract description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 abstract description 2
- 239000008101 lactose Substances 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 abstract 2
- SRBFZHDQGSBBOR-QMKXCQHVSA-N alpha-L-arabinopyranose Chemical compound O[C@H]1CO[C@@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-QMKXCQHVSA-N 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 244000000626 Daucus carota Species 0.000 description 6
- 235000002767 Daucus carota Nutrition 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 241000700159 Rattus Species 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000003178 anti-diabetic effect Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241001530105 Anax Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 125000003572 L-arabinopyranosyl group Chemical group [H]O[C@@]1([H])C([H])([H])OC([H])(*)[C@]([H])(O[H])[C@@]1([H])O[H] 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000013551 empirical research Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000008024 pharmaceutical diluent Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59145189A JPS6124597A (ja) | 1984-07-12 | 1984-07-12 | 抗糖尿病剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59145189A JPS6124597A (ja) | 1984-07-12 | 1984-07-12 | 抗糖尿病剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6124597A true JPS6124597A (ja) | 1986-02-03 |
| JPH0369328B2 JPH0369328B2 (de) | 1991-10-31 |
Family
ID=15379480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59145189A Granted JPS6124597A (ja) | 1984-07-12 | 1984-07-12 | 抗糖尿病剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6124597A (de) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999063979A3 (en) * | 1998-06-08 | 2000-03-16 | Sambasiva R Chavali | Inhibition of δ-9-desaturase activity by saponins |
| WO2002038166A3 (en) * | 2000-11-07 | 2003-07-10 | Univ Chicago | Ginseng berry extracts and pharmaceutical compositions therefrom |
| KR100735573B1 (ko) | 2005-10-06 | 2007-07-04 | 주식회사 비티진 | 진세노사이드를 유효성분으로 하는 혈당강하제 조성물 |
| WO2011002033A1 (ja) | 2009-06-30 | 2011-01-06 | ライオン株式会社 | 糖代謝改善剤及び糖代謝改善組成物 |
| JP2011026314A (ja) * | 2009-06-30 | 2011-02-10 | Lion Corp | 糖代謝改善剤及び糖代謝改善組成物 |
| JP2011026313A (ja) * | 2009-06-30 | 2011-02-10 | Lion Corp | 糖代謝改善剤及び糖代謝改善組成物 |
| CN104800558A (zh) * | 2015-04-27 | 2015-07-29 | 唐玉厚 | 一种治疗糖尿病的药物 |
| CN104857367A (zh) * | 2015-05-13 | 2015-08-26 | 柳州市耕青科技有限公司 | 一种降血糖的中药饮方 |
-
1984
- 1984-07-12 JP JP59145189A patent/JPS6124597A/ja active Granted
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999063979A3 (en) * | 1998-06-08 | 2000-03-16 | Sambasiva R Chavali | Inhibition of δ-9-desaturase activity by saponins |
| WO2002038166A3 (en) * | 2000-11-07 | 2003-07-10 | Univ Chicago | Ginseng berry extracts and pharmaceutical compositions therefrom |
| KR100735573B1 (ko) | 2005-10-06 | 2007-07-04 | 주식회사 비티진 | 진세노사이드를 유효성분으로 하는 혈당강하제 조성물 |
| WO2011002033A1 (ja) | 2009-06-30 | 2011-01-06 | ライオン株式会社 | 糖代謝改善剤及び糖代謝改善組成物 |
| JP2011026314A (ja) * | 2009-06-30 | 2011-02-10 | Lion Corp | 糖代謝改善剤及び糖代謝改善組成物 |
| JP2011026313A (ja) * | 2009-06-30 | 2011-02-10 | Lion Corp | 糖代謝改善剤及び糖代謝改善組成物 |
| KR20160132134A (ko) | 2009-06-30 | 2016-11-16 | 라이온 가부시키가이샤 | 당 대사 개선제 및 당 대사 개선 조성물 |
| CN104800558A (zh) * | 2015-04-27 | 2015-07-29 | 唐玉厚 | 一种治疗糖尿病的药物 |
| CN104857367A (zh) * | 2015-05-13 | 2015-08-26 | 柳州市耕青科技有限公司 | 一种降血糖的中药饮方 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0369328B2 (de) | 1991-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106074971B (zh) | 一种降血糖中药组合物及制备方法与应用 | |
| JP2002526379A (ja) | インシュリン活性を増強する組成物およびその方法 | |
| US7985848B2 (en) | Pharmaceutical composition for preventing and treating diabetes or glucose control abnormality comprising ginsenosides | |
| US4985248A (en) | Pharmaceutical composition containing a safe extracts of fruits and vegetables for the treating and preventing of diabetes | |
| US5980902A (en) | Compositions for treating and preventing diabetes, impaired glucose tolerance and related symptoms, and methods for preparing and using such compositions | |
| CN103520199A (zh) | 枸杞多糖在治疗糖尿病药物中的应用 | |
| EP2172206A1 (de) | Verfahren für einen sequoyitol enthaltenden extrakt aus dem genus trifolium, sojabohne und ginkgo biloba und seine anwendung | |
| JPS6124597A (ja) | 抗糖尿病剤 | |
| CN1294912A (zh) | 一类新型降低血糖化合物 | |
| Jouad et al. | Cholesterol-lowering activity of the aqueous extract of Spergularia purpurea in normal and recent-onset diabetic rats | |
| CN102716135B (zh) | 羽扇豆酮在制备预防或治疗糖尿病的产品中的应用 | |
| US5086043A (en) | Production of Saponins of Lichi | |
| KR20030023232A (ko) | 인삼 또는 돌외로부터 사포닌을 추출하는 방법 및 이방법에 따라 추출된 사포닌을 함유하는 식품 | |
| CN112494502B (zh) | 一种用于血虚证补血的糖类组合物 | |
| JPH09241157A (ja) | リソスペルメートb含有肝臓保護作用医薬組成物 | |
| RU2114617C1 (ru) | Антидиабетическое средство на основе янтарной кислоты | |
| Yokozawa et al. | The effect of ginsenoside-Rb2 on nitrogen balance | |
| CN106109554A (zh) | 一种改善胰岛素抵抗的组合物 | |
| KR100256867B1 (ko) | 엘-무스콘의 의약용도 | |
| JPS5948421A (ja) | 抗高脂血症剤 | |
| Saiyad Moinali et al. | To investigate antidiabetic potential of Martynia annua linn. flower extracts in wistar rats | |
| US20110071225A1 (en) | Method for obtaining a sequoyitol-containing extract from genus nephrolepis and uses thereof | |
| CN1320440A (zh) | 大花红景天有效成分制剂及制备方法 | |
| US20100197803A1 (en) | Method for obtaining a sequoyitol-containing extract from a plant of the genus of trifolium, leguminosae or ginkoaceae and uses thereof | |
| KR100543352B1 (ko) | 당뇨병 치료에 효능이 있는 혼합 생약재 추출물 |